Can India lead the way in neglected diseases innovation?

Zakir Thomas, Gautam Kumar Saha, Kappoori Madhavan Gopakumar, Nirmal Kumar Ganguly
Author Information
  1. Zakir Thomas: Central Board of Direct Taxes, Department of Revenue, Ministry of Finance, New Delhi, India.
  2. Gautam Kumar Saha: Apollo Hospitals Educational and Research Foundation, New Delhi, India.
  3. Kappoori Madhavan Gopakumar: Third World Network, Geneva, Switzerland.
  4. Nirmal Kumar Ganguly: Apollo Hospitals Educational and Research Foundation, New Delhi, India ganguly.nk@aherf.net.

Abstract

No abstract text available.

References

  1. PLoS One. 2014 Jul 01;9(7):e99381 [PMID: 24983989]
  2. Am J Trop Med Hyg. 2015 Mar;92(3):513-7 [PMID: 25510715]
  3. PLoS One. 2014 Jun 18;9(6):e100220 [PMID: 24941345]
  4. PLoS Negl Trop Dis. 2012;6(8):e1750 [PMID: 22953004]
  5. Vaccine. 2016 Mar 18;34(13):1551-1558 [PMID: 26896684]
  6. BMJ Glob Health. 2018 May 3;3(3):e000709 [PMID: 29736277]
  7. Indian J Public Health. 2016 Jul-Sep;60(3):171-5 [PMID: 27561394]
  8. Symbiosis. 2010 Jul;51(1):55-65 [PMID: 20730111]
  9. BMJ. 2000 Mar 11;320(7236):668 [PMID: 10710568]
  10. Indian J Public Health. 1994 Apr-Jun;38(2):39-43 [PMID: 7530695]
  11. PLoS Med. 2017 Jan 3;14(1):e1002191 [PMID: 28045908]
  12. Diagn Microbiol Infect Dis. 2004 Sep;50(1):15-24 [PMID: 15380274]
  13. BMJ. 2010 Sep 22;341:c4777 [PMID: 20861098]
  14. Soc Hist Med. 2019 Aug;32(3):609-630 [PMID: 31384102]
  15. ISME J. 2018 Jan;12(1):277-288 [PMID: 29099491]
  16. WHO South East Asia J Public Health. 2012 Jan-Mar;1(1):113-115 [PMID: 28612785]
  17. Sci Rep. 2016 Sep 14;6:33059 [PMID: 27624408]

MeSH Term

Biomedical Research
Diffusion of Innovation
Drug Approval
Drug Development
Health Policy
Humans
India
Neglected Diseases
Translational Research, Biomedical

Word Cloud

Created with Highcharts 10.0.0CanIndialeadwayneglecteddiseasesinnovation?

Similar Articles

Cited By